Inducing multiple antibodies to treat squamous cell esophageal carcinoma.
Isamu HoshinoYoshihiro NabeyaNobuhiro TakiguchiHisashi GunjiFumitaka IshigeYosuke IwatateAkiko KuwajimaFumiaki ShiratoriRei OkadaHideaki ShimadaPublished in: BMC cancer (2020)
The detection rates of LGALS1, HCA25a, HCC-22-5, and HSP70 were 10% higher in patients with ESCC. Gene overexpression may be involved in such antibody production. These four antibodies were applied as a panel in comparison with conventional tumor markers. Moreover, it was confirmed that the combination of this panel and the conventional tumor markers significantly improved the positive rate.